Welcome to our new website! If this is the first time you are logging in on the new site, you will need to reset your password. Please contact us at firstname.lastname@example.org if you need assistance.
Your membership opens the door to free learning resources on demand. Check out the Member Knowledge Center for free webcasts, publications and online courses.
The highly-anticipated fifth edition is here! Get the must-have resource for achieving compliance with medical device regulations.
Hear from leaders around the globe as they share insights about their experiences and lessons learned throughout their certification journey.
The marathon becomes an ultra-marathon
Belsky first asked panelists how they kept their staff engaged and motivated for the duration of a public health emergency that has stretched longer than anyone could have conceived it would when, in March 2020, the US saw its first lockdowns.
“So it has been a marathon, and it has taken its toll,” acknowledged Peter Marks, head of FDA’s Center for Biologics Evaluation and Research (CBER), adding frankly that some staff members have fared better than others.
Tags: coronavirus, EMA, FDA, RAPS, RAPS Convergence, US